Objective: To compare the effect of surface finishing and polishing protocols on the surface roughness (Ra) of methacrylate-based and silorane-based resin composites.
Methods And Materials: Fifty specimens (5 mm x 2 mm) of each composite material were prepared using a split mold: Filtek™ Supreme Ultra (3M ESPE), Tetric EvoCeram® (Ivoclar Vivadent), Tetric Ceram™ HB (Ivoclar Vivadent), and Filtek™ LS Low Shrink (3M ESPE). Specimens were divided into five groups (n = 10) according to the following procedures: G1 - 15-µm fine diamond bur (FDB); G2 - 15-µm FDB followed by a 20-fluted tungsten carbide bur; G3 - 15-µm FDB followed by diamond-impregnated micropolishing points (D-FINE Double Diamond Polishing System, Clinician's Choice); G4 - 15-µm FDB followed by diamond-impregnated micropolishing points (Flame Point Pre-polisher and Shine, Brassseler USA); and G5 - 15-µm FDB followed by the application of a surface sealer (PermaSeal®, Ultradent Products, Inc.). Ra was measured in three different regions using a surface profilometer (Mitutoyo Surfest SJ-210, Mitutoyo America).
Results: Multiple comparisons were obtained using a one-way ANOVA with Tukey's B rank order test ( = 0.05). No significant differences in Ra were observed among the resin composites tested in the same condition. The use of a FDB generated the highest roughness values, while the use of a surface sealer resulted in the lowest roughness values for all resin composites tested (P < .05). No significant difference in Ra was observed between the use of a multi-fluted carbide bur and the rubber point D-FINE Double Diamond Polishing System for all resin composites tested.
Download full-text PDF |
Source |
---|
Background: Anakinra is an interleukin-1 receptor antagonist (IL-1Ra). Since IL-1 has been shown to play a key role in the etiology of different autoinflammatory diseases, blocking its pathway has become an important therapeutic target, even in neonates.
Aims: We aimed to report our experience in using anakinra to treat specific neonatal inflammatory conditions.
Vet Dermatol
January 2025
Department of Medicine and Epidemiology, University of California, Davis, California, USA.
Background: Psittacines (parrots and their allies) are kept under human care as companion animals, live exhibit specimens in zoological institutions and occasionally as research subjects. Cutaneous disorders such as feather destructive behaviour (FDB) and pododermatitis are commonly noted in clinical reviews, case reports and text book chapters.
Hypothesis/objectives: To document the type, signalment associations and prevalence of cutaneous disorders in a large number of captive psittacines in an academic referral teaching hospital population.
AJNR Am J Neuroradiol
January 2025
Department of Neuroradiology (E.L.F., M.M.M., K.S.K.), Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona
Background And Purpose: Normal pressure hydrocephalus (NPH) is a diagnostic challenge because its clinical symptoms and imaging appearance resemble normal aging and other forms of dementia. Identifying NPH is essential so that patients can receive timely treatment to improve gait distortion and quality of life. An automated marker of NPH was developed and evaluated on clinical CT images, and its utility was assessed in a large patient cohort.
View Article and Find Full Text PDFAm J Physiol Cell Physiol
December 2024
Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
Plasma membrane repair (PMR) restores membrane integrity of cells, preventing cell death in vital organs, and has been studied extensively in skeletal muscle. Dysferlin, a sarcolemmal Ca-binding protein, plays a crucial role in PMR in skeletal muscle. Previous studies have suggested that PMR employs membrane trafficking and membrane fusion, similar to neurotransmission.
View Article and Find Full Text PDFNat Biomed Eng
December 2024
Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Resistance to chimaeric antigen receptor (CAR) T cell therapy develops through multiple mechanisms, most notably antigen loss and tumour-induced immune suppression. It has been suggested that T cells expressing multiple CARs may overcome the resistance of tumours and that T cells expressing receptors that switch inhibitory immune-checkpoint signals into costimulatory signals may enhance the activity of the T cells in the tumour microenvironment. However, engineering multiple features into a single T cell product is difficult because of the transgene-packaging constraints of current gene-delivery vectors.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!